BMO Capital Reiterates Outperform Rating on 4D Molecular Therapeutics (FDMT)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NASDAQ: FDMT) | Delayed: 11.96 +0.93 (8.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.03 | 52 Week High | $ | |||
| Open | $10.96 | 52 Week Low | $ | |||
| Day High | $11.99 | P/E | N/A | |||
| Day Low | $10.75 | EPS | $ | |||
| Volume | 1,134,654 | |||||
